Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Effect of Ca2EDTA on Zinc Mediated Inflammation and Neuronal Apoptosis in Hippocampus of an In Vivo Mouse Model of Hypobaric Hypoxia

  • Udayabanu Malairaman,

    Current address: Department of Pharmacy, Jaypee University of Information Technology, Waknaghat, India

    Affiliation Dr.B.R.Ambedkar Center for Biomedical Research, University of Delhi, Delhi, India

  • Kumaran Dandapani,

    Affiliation Dr.B.R.Ambedkar Center for Biomedical Research, University of Delhi, Delhi, India

  • Anju Katyal

    anju_katyal@yahoo.com

    Affiliation Dr.B.R.Ambedkar Center for Biomedical Research, University of Delhi, Delhi, India

Abstract

Background

Calcium overload has been implicated as a critical event in glutamate excitotoxicity associated neurodegeneration. Recently, zinc accumulation and its neurotoxic role similar to calcium has been proposed. Earlier, we reported that free chelatable zinc released during hypobaric hypoxia mediates neuronal damage and memory impairment. The molecular mechanism behind hypobaric hypoxia mediated neuronal damage is obscure. The role of free zinc in such neuropathological condition has not been elucidated. In the present study, we investigated the underlying role of free chelatable zinc in hypobaric hypoxia-induced neuronal inflammation and apoptosis resulting in hippocampal damage.

Methods

Adult male Balb/c mice were exposed to hypobaric hypoxia and treated with saline or Ca2EDTA (1.25 mM/kg i.p) daily for four days. The effects of Ca2EDTA on apoptosis (caspases activity and DNA fragmentation), pro-inflammatory markers (iNOS, TNF-α and COX-2), NADPH oxidase activity, poly(ADP ribose) polymerase (PARP) activity and expressions of Bax, Bcl-2, HIF-1α, metallothionein-3, ZnT-1 and ZIP-6 were examined in the hippocampal region of brain.

Results

Hypobaric hypoxia resulted in increased expression of metallothionein-3 and zinc transporters (ZnT-1 and ZIP-6). Hypobaric hypoxia elicited an oxidative stress and inflammatory response characterized by elevated NADPH oxidase activity and up-regulation of iNOS, COX-2 and TNF-α. Furthermore, hypobaric hypoxia induced HIF-1α protein expression, PARP activation and apoptosis in the hippocampus. Administration of Ca2EDTA significantly attenuated the hypobaric hypoxia induced oxidative stress, inflammation and apoptosis in the hippocampus.

Conclusion

We propose that hypobaric hypoxia/reperfusion instigates free chelatable zinc imbalance in brain associated with neuroinflammation and neuronal apoptosis. Therefore, zinc chelating strategies which block zinc mediated neuronal damage linked with cerebral hypoxia and other neurodegenerative conditions can be designed in future.

Introduction

Hypobaric hypoxia experienced at high altitude has deleterious effects on the Central Nervous System (CNS) mediated through glutamate excitotoxicity, cholinergic dysfunction, oxidative stress and neurodegeneration, [1], [2], [3]. Clinical as well as experimental studies demonstrated the important role played by reactive oxygen species in high altitude hypoxia induced pathological changes in the forebrain region [4], [5]. Reactive oxygen species (ROS) are known to stabilize hypoxia inducible factor-1 α (HIF-1α), a transcription factor which modulates the expression of genes related to hypoxic stress [6], [7], [8], [9]. Further, inducible nitric oxide synthase (iNOS) derived reactive nitrogen species (RNS) and NADPH oxidase derived ROS, have been implicated in inflammation mediated neuronal cell death [10], [11], [12], [13]. Free oxy radicals are known to induce DNA damage resulting in the activation of poly(ADP ribose) polymerase (PARP) [14], a multifaceted enzyme involved in various cytotoxic mechanisms like inflammation, mitochondrial dysfunction, necrosis and apoptosis. Emerging body of evidences suggest apoptosis as the predominant form of neuronal death following cerebral hypoxia [3]. Apoptosis is known to involve cleavage of chromosomal DNA into nucleosomal units by caspases, and activation of Bcl-2 family of proteins in response to apoptotic signals such as cell stress, free radical damage etc. The relative contribution of signaling cascades in mediating neuronal damage hold the key to development of effective therapeutic strategies against hypobaric hypoxia-induced neuronal injury. Glutamate mediated calcium excitoxicity and subsequent neurodegeneration is associated with memory dysfunction on exposure to hypobaric hypoxia [2], [15]. Recently, it has been indicated that zinc, which is co-localized and released along with glutamate, might induce neurophysiological alterations similar to calcium [16]. Further, increased levels of intraneuronal free zinc have been reported in major neurological disorders such as Alzheimer‘s disease, Parkinson‘s disease, amyotrophic lateral sclerosis, stroke, epilepsy, etc. [17], [18], [19]. In our previous study, we reported that hypobaric hypoxia elicited accumulation of free chelatable zinc in the CA3 region of hippocampus accompanied by significant neuronal damage. Chelation of free zinc with Ca2EDTA succeed in attenuation of cholinergic dysfunction and neuronal loss associated with memory impairment [20]. Evidences suggest that excess free zinc can be detrimental and exacerbate neuronal damage in vivo and in vitro [21], [22], [23], [24]. In fact, the zinc chelator Ca2EDTA, both in vivo and in vitro, has been shown to reduce zinc-induced neurotoxicity [25]. Although, the detrimental role of free zinc in a myriad of neurological conditions is well documented, the mechanism of zinc-mediated neuropathogenesis has not been fully illustrated especially in hypobaric hypoxia. Therefore, present study was designed to investigate the effect of Ca2EDTA, a specific zinc chelator, on the mechanism underlying hypobaric hypoxia induced neuronal inflammation and apoptosis in Balb/c mice.

Materials and Methods

Ethics Statement

The procedures and experimental protocols related to use of Balb/c mice were approved by the Institutional Animal Ethics Committee of Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi. All efforts were made to minimize animal sufferings and to reduce the number of animals used.

Animals and Experimental groups

All experiments were performed on adult male Balb/c mice (8–10 wks old, 25–30 g), maintained in animal research facility with 12 h dark/light cycle and 25±2°C temperature at Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi. Animals had free access to food and water ad libitum. Balb/c mice were divided into four groups as follows: Normoxia, Normoxia treated with Ca2EDTA (1.25 mM/kg in normal saline, i.p.), Hypoxia and Hypoxia treated with Ca2EDTA.

Induction of hypobaric hypoxia

Male Balb/c mice were either exposed to hypobaric hypoxia (corresponding to an altitude of 25000 feet for 6 h daily) for 3 days in a specially designed decompression chamber (Model No.SS7001, Seven Stars, India) after gradual adaptation over a period of 1 hr or were kept at room air pressure. Mice had free access to food and water. The rate of ascent to the desired altitude and descent to sea level were at 700 ft/min. The chamber temperature was maintained at 26±2°C.

Hippocampus homogenate

The total hippocampal homogenate was prepared for immunoblotting and biochemical analysis as described earlier [3]. Briefly, animals were euthanized under excess anesthesia and their brains were harvested to dissect hippocampus [26]. The hippocampus was weighed immediately and homogenized in 10 volumes of cold homogenization buffer (containing 1% IPEGAL CA 630, 10 mM Tris, 150 mM NaCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM/L bezamidine, 2 µg/mL aprotinin, 10 µg/mL leupeptin and 5 µg/mL pepstatin). The homogenate was centrifuged at 16,000 g for 20 min at 4°C and the supernatant was stored at −80°C until used. Protein concentration was estimated by the method of Bradford et al using spectrophotometer (UV-1601 Shimadzu) at 595 nm.

Reverse transcriptase PCR amplification

Total RNA was isolated from hippocampus using TRI reagent (Ambion Inc.) and processed for reverse transcription PCR amplification (RT-PCR) as described earlier [3]. The reverse transcription of 5 µg of total RNA was performed using First strand cDNA kit (Fermentas). For polymerase chain reaction 1 µl of cDNA, 1 µl of primers (each 5 pmole), 2 µl of 10× reaction buffer, 0.6 µl of 50 mM MgCl2 and 1 unit of DNA polymerase (Biotools, Inc.) was made up to 20 µl with DNase/RNase free water. PCR amplification was carried out by employing a set of specific primers. PCR products were resolved on 1.5% agarose gel and densitometry analysis of PCR products was carried out using Gene Snap software (Gene Tools; Syngene, MD, USA).

Western blot analysis

Hippocampal homogenate equivalent to 30–35 µg of total protein was denatured with laemmli loading buffer by heating at 95°C for 5 minutes and the samples were resolved on 10–16% SDS-PAGE and electroblotted to nitrocellulose membrane using BioRad semi-dry transblot. The transfer buffer contained in addition, 2 mM CaCl2 for metallothionein. Blots were blocked with 3% BSA in PBST over night at 4°C and then incubated with respective primary antibodies - rabbit polyclonal IgG anti- mouse metallothionein 3 (1: 5000); mouse monoclonal IgG anti-mouse Bcl-2, mouse monoclonal IgG anti-mouse Bax (eBiosciences, USA) (1∶500); mouse monoclonal IgG anti-mouse inducible nitric oxide synthase (iNOS) (1: 5000) (Pharmingen, BD Biosciences, USA); anti-mouse GAPDH (1∶5000) (Novus Biologicals, USA) in PBS for 2.5 h at room temperature/overnight at 4°C and then washed thrice with PBS. The blots were then incubated with secondary IgG HRP conjugated goat anti-rabbit (1: 5000) or donkey anti-mouse (1: 5000) antibodies (Santa Cruz Biotechnology, CA, USA) in PBS at room temperature for 2 h. After washing, the blots were developed with 0.06% 3, 3′-diaminobenzidine tetrahydrochloride (DAB), 0.025% cobalt chloride in PBS and 0.01% hydrogen peroxide. The blot images were captured and band density analysis was performed using Gene Snap software (Gene Tools; Syngene, MD, USA). Values of the band density were normalized to the level of respective GAPDH intensity.

Immunofluorescence

The animals were anesthetized (pentobarbital-sodium 50 mg/kg i.p.) and perfused intracardially with heparinized (10 U/ml) 0.1 M PBS (pH 7.4) followed by 4% paraformaldehyde in PBS, the whole brain was harvested and stored in a solution of 30% sucrose and 10% glycerol at −80°C until use. Thin sections (5 µm) of the hippocampal region were made using cryotome (CM 1850 Leica, Heidelberg, Germany) as described previously [27] and then processed for TUNEL staining and immunofluorescence studies. Briefly, the sections were permeabilized with 0.1% IPEGAL CA 630 in PBS (pH 7.4) and blocked with 3% BSA in PBS (pH 7.4) for 1 h at 37°C followed by overnight incubation with primary antibodies- rabbit polyclonal IgG anti-mouse metallothionein3 (1: 150); mouse monoclonal IgG anti-mouse iNOS (1∶200); mouse monoclonal IgG anti-mouse COX-2 (1∶150) (Pharmingen, BD Biosciences, USA); rabbit polyclonal IgG anti-mouse HIF-1α (1∶200) and rabbit polyclonal IgG anti-mouse TNF-α (1∶100) (eBioscience, USA). The sections were then washed thrice with PBS, incubated with FITC labeled respective secondary antibody (Santa-cruz biotech) for 1 hour in a dark room and counterstained with Hoechst 33342 (Fluka). The sections were mounted with glycerol/PBS (9∶1), observed under 40× objectives on Nikon Eclipse E600 with Nikon Y-FL Epifluorescence attachment (Tokyo, Japan) and images were acquired with Evolution VF camera followed by analysis with Image-Pro Plus version 5.1.2 software (Mediacybernetics).

Estimation of Nitric Oxide

The Nitric oxide levels were determined as nitrite plus nitrate as per previous report [3]. The total nitrate from the hippocampal homogenate was reduced to nitrite by using 2% ammonium molybdate and 4% ferrous ammonium sulphate and quantified by using Greiss reagent (1% sulphanilamide, 0.1% naphthylethylenediamine dihydrochloride (NEDA) in 5% orthophosphoric acid) at 540 nm spectrophotometrically.

Lipid peroxidation

Malondialdehyde (MDA) formation is an indicator to assess oxidative stress induced lipid peroxidation as described by Ohkawa et al, 1979 [28]. Hippocampal homogenate equivalent to 100 µg of protein was mixed with 1 ml of 20% acetic acid (pH 3.5), 1 ml of 0.67% thio barbituric acid and 0.1 ml SDS (8%) and then heated at 100°C for 1 h. The pink chromogen formed in the reaction mixture was extracted with n-butanol and the absorption was measured at 535 nm. The results were expressed as nmol/h/mg protein of MDA formed using a molar extinction coefficient of 1.56×105 M−1cm−1.

NADPH oxidase activity

The fluorogenic oxidation of dihydroethidium (DHE) to ethidium was used as a measure of superoxide anions to determine the NADPH Oxidase activity [29]. In a microplate (Perkin-Elmer), freshly prepared hippocampus homogenates were incubated with DHE (10 µmol), salmon testes DNA (0.5 mg/ml, Sigma)in the presence or absence of β-NADPH (0.1 mM, Sigma) as substrate for 30 min at 37°C in a dark chamber. Ethidium-DNA fluorescence was measured at an excitation of 485±40 nm and an emission of 590±35 nm using fluorescence plate reader (Bio-Tek Instruments, Winooski, VT).

PARP assay

Hippocampal homogenate equivalent to 50 µg of total protein was used for the determination of PARP-1 activity using HT Universal Colorimetric PARP-1 Assay Kit (Trevigen Inc, Md). The assay components were added according to manufacturer's instructions and reaction was terminated by adding 50 µl per well of 5% phosphoric acid and the absorbance was read at 450 nm.

Caspase assay

The Caspase 3, 8 and 9 activity assays were performed using Caspase Fluorometric Assay kit (BioVision, USA). The assay is based on estimation of the intensity of fluorescence produced by cleavage of specific sequence (substrate) coupled with a fluorogenic compound, 7-amino-4-trifluoromethyl coumarin (AFC) which serves as a substrate. The tissue homogenate equivalent to 100 µg of total protein was diluted with 2× reaction buffer containing 10 mM DTT. Five microlitre of the respective substrate (Caspase-3: DEVD-AFC; Caspase-8: IETD-AFC; Caspase-9: LEHD-AFC) was added to the reaction mixture in micro-plate and incubated at 37°C for 1–2 h. The fluorescence intensity was measured using Bio-Tek FL600 fluorescence plate reader (Bio-Tek Instruments, Winooski, VT).

Apoptotic neuronal death detection by TUNEL method:

To identify the apoptotic neuronal death in the sections, terminal deoxynucleotidyl transferase mediated biotinylated dUTP nick end-labeling (TUNEL) staining was performed with the Apo-BrdU-IHC In Situ DNA Fragmentation Assay Kit, following the manufacture's instruction (BioVision, Inc., USA) and developed with 3'3-diaminobenzidine in the presence of H2O2/urea tablet provided in the kit. After TUNEL reaction, the sections were counterstained with methyl green. The sections were mounted with glycerol/PBS (9∶1) and observed under 40× objectives on Nikon Eclipse E600 with Evolution VF camera. The captured images were analyzed with Image-Pro Plus version 5.1.2 software (Mediacybernetics).

Statistical analysis

Data were analyzed using Graph Pad Prism 4.0 and Sigmaplot 9.0. All results were expressed as mean ± S.E.M for groups of 5–6 animals measured individually. Data were analyzed by one way analysis of variance (ANOVA) followed by post hoc comparison using Tukey's multiple comparison test. The p value <0.05 was considered statistically significant.

Results

Hypobaric hypoxia is found to perturb the expression of a wide range of genes, but the homeostasis of free zinc released and its effect on inflammation and apoptosis has not been reported to the best of our knowledge. In the present study, we explored the effect of zinc chelation using Ca2EDTA on the expression of genes related to zinc homeostasis, inflammation and apoptosis in the hippocampus.

Effect of Ca2EDTA on hypobaric hypoxia induced alteration in the expression of genes that regulate zinc homeostasis

The zinc homeostasis is maintained by transporters that are involved in the influx and efflux of zinc across the membrane and metallothioneins that buffer the intracellular free zinc. In the present study, we observed that hypobaric hypoxia significantly (P<0.01) up-regulated hippocampal mRNA expression of ZIP-6 as compared to normoxia and normoxia treated groups (one-way ANOVA: F(3,17) = 80.07). The Ca2EDTA treated hypoxic animals showed significant (P<0.05) decrease in the mRNA expression of ZIP-6 as compared to hypoxic group (Fig 1A). Similarly the zinc transporter-1 (ZnT-1) mRNA expression was also significantly (P<0.01) increased in the hypoxic group as compared with normoxia and normoxia treated groups (one-way ANOVA: F(3,20) = 66.40). The Ca2EDTA treatment significantly (P<0.05) decreased the mRNA expression of ZnT-1 as compared to hypoxic group (Fig 1B).

thumbnail
Figure 1. Effect of Ca2EDTA administration on the expression of genes that regulate zinc homeostasis in the hippocampus of animals after exposure to hypobaric hypoxia.

Graph represents the relative OD of ZIP-6 (335 bp) [A], ZnT-1 (249 bp) [B] and MT-3 (123 bp) [C] mRNAs expression in the hippocampus. The expression of all genes were normalized to the level of GAPDH mRNA and representative of three experiments in duplicate. ** p<0.01, # p<0.05. * compared hypoxia vs normoxia and normoxia treated with Ca2EDTA. # compared hypoxia treated Ca2EDTA vs hypoxia. N-normoxia, NED-normoxia treated with Ca2EDTA, IH-hypoxia and HED-hypoxia treated with Ca2EDTA. Lane 1,2-normoxia, Lane 3,4-normoxia treated with Ca2EDTA, Lane 5,6- hypoxia and Lane 7,8- hypoxia treated with Ca2EDTA. M indicate marker lane (A, B and C). ZIP-6: Forward-5′-AGCAGCCGACGATGTTGGAAGA-3′, Reverse: 5′- TGAAGGCAGCACCAATAGCAAG-3′ (335 bp); ZnT-1: Forward: 5′-TCGTGAATGCCTTGGTCTTTTA-3′, Reverse: 5′-GTTTGTAGAAGAATGAGAGCAGACT-3′ (249 bp); MT-3: Forward: 5′-CTGTCCTACTGGTGGTTCCTGC-3′, Reverse: 5′- GTCCTTGGCACACTTCTCACATC-3′ (123 bp).

https://doi.org/10.1371/journal.pone.0110253.g001

The metallothionein-3 (MT-3) mRNA expression was significantly (P<0.01) increased in the hypoxic group as compared with normoxia, normoxia treated and hypoxic treated groups (one-way ANOVA: F(3,20) = 17.45). The Ca2EDTA treated hypoxic animals showed significant (P<0.05) decrease in the mRNA expression of MT-3 (Fig 1C). Immunoblot analysis also showed that the hypobaric hypoxia significantly (P<0.05) increased the MT-3 protein expression as compared to normoxia and normoxia treated group (one-way ANOVA: F(2,12) = 11.45). The observed increase in MT-3 protein expression was significantly (P<0.05) reduced by the zinc chelator (Fig 2 C). Immunofluorescence studies also substantiated the findings that hypobaric hypoxia significantly (P<0.001) increased MT-3 expression in the hippocampus CA3 region and zinc chelation significantly (P<0.001) reduced the MT-3 expression in the hippocampus (one-way ANOVA: F(2,41) = 26.12) (Fig 2).

thumbnail
Figure 2.

A. Photomicrograph shows the expression of MT-3 counter stained with Hoechst 33342 in CA3 hippocampal region of Normoxia (a), Normoxia treated with Ca2EDTA (b), Hypoxia (c), Hypoxia treated with Ca2EDTA (d) (Magnification ×400). B. Graph represents relative mean fluorescence intensity of MT-3 expression in hippocampal sections of CA3 region.C. Western blot analysis and quantification of MT-3 ***, ### indicate p<0.001. * compared hypoxia with normoxia treated with Ca2EDTA. # compared hypoxia treated Ca2EDTA vs hypoxia. NED-normoxia treated with Ca2EDTA, IH-hypoxia and HED-hypoxia treated with Ca2EDTA. Scale bar  = 5 µm.

https://doi.org/10.1371/journal.pone.0110253.g002

Effect of Ca2EDTA on hypobaric hypoxia induced alteration in expression of HIF-1α

Brain, as a main consumer of energy, is particularly susceptible to hypoxia leading to neuronal dysfunction and cell death. HIF-1α plays a pivotal role in the signaling pathway of molecular and cellular adaptation to hypoxia. We observed that there was no significant change in the mRNA expression of HIF-1α in any of the groups employed (one-way ANOVA: F(3,17) = 0.2386). But immunofluorescence studies demonstrated significantly (P<0.001) elevated levels of HIF-1α protein expression in the hypoxic group as compared with normoxia and normoxic Ca2EDTA treated animals (one-way ANOVA: F(2,14) = 30.24). Ca2EDTA treatment significantly (P<0.01) reduced the HIF-1α expression in the hippocampus CA3 region of hypoxic animals Fig (3).

thumbnail
Figure 3. Effect of Ca2EDTA on hypobaric hypoxia induced alteration in expression of HIF-1α.

Photomicrographs show the expression of HIF-1α counter stained with Hoechst 33342 (A) in CA3 hippocampal region of normoxia (a), normoxia treated with Ca2EDTA (b), hypoxia (c) and hypoxia treated with Ca2EDTA (d) (Magnification ×400). Graph represents relative mean fluorescence intensity of HIF-1α expression in hippocampal sections of CA3 region (B) and HIF-1α mRNA (216 bp) expression and relative OD (C) in hippocampus. *** indicate p<0.001;* compared hypoxia vs normoxia treated with Ca2EDTA. ## indicate p<0.01, # compared hypoxia hreated Ca2EDTA vs hypoxia. NED-Normoxia Treated with Ca2EDTA, IH-Hypoxia and HED-Hypoxia Treated with Ca2EDTA. Lane 1,2-Normoxia, Lane 3,4-Normoxia treated with Ca2EDTA, Lane 5,6- Hypoxia and Lane 7,8- Hypoxia treated with Ca2EDTA. M indicate Marker lane. HIF-1α – Forward primer: 5′ - AGAAACCTACCATCACTGCCACT- 3′, Reverse primer: 5′ – TGTTCTATGACTCTCTTTCCTGC - 3′ (216 bp). Scale bar  = 5 µm.

https://doi.org/10.1371/journal.pone.0110253.g003

Effect of Ca2EDTA on hypobaric hypoxia induced alteration in the expression of inflammatory mediators

Inflammatory neurodegeneration is implicated in diseases like Alzheimer's, Parkinson's, Multiple sclerosis, etc. In the present study, we investigated the effect of Ca2EDTA on the status of inflammatory mediators expression in the hippocampus. We observed that normoxia, normoxia treatment and hypoxia treatment did not show any detectable mRNA expression of iNOS. Hypobaric hypoxia resulted in significantly (P<0.001) increased iNOS mRNA expression in the hippocampus, which was significantly (P<0.001) reduced by Ca2EDTA treatment (one-way ANOVA: F(3,20) = 88.25) (Fig 4B). Similarly, immunoblot (one-way ANOVA: F(2,15) = 34.65) (Fig 4C) as well as immunofluorescence (one-way ANOVA: F(2,28) = 16.29) (Fig 5A & B) studies showed significantly (P<0.001) elevated iNOS protein expression in hipocampii of the hypoxic group. Administration of zinc chelator to hypoxic animals significantly (P<0.01) reduced the iNOS expression as compared to untreated hypoxic animals. Further, hypoxia significantly (P<0.001) increasedTNF α mRNA level (one-way: ANOVA F(3,20) = 71.52) (Fig 4A) and protein expression (one-way ANOVA: F(2,19) = 9.334) (Fig 5E & F) as compared to normoxia and normoxia treated group. Ca2EDTA treatment to hypoxic animals significantly (P<0.05) attenuated the elevation in TNF-α expression as compared to hypoxic group. Immunofluorescence results revealed that COX-2 expression was significantly (P<0.001) elevated in the hypoxic group as compared with normoxia and normoxia Ca2EDTA treated group (one-way ANOVA: F(2,15) = 20.06). The Ca2EDTA treated hypoxic group significantly (P<0.01) reduced COX-2 expression as compared to hypoxic group (Fig 5C& D).

thumbnail
Figure 4. Effect of Ca2EDTA on hypobaric hypoxia induced alteration in the expression of inflammatory mediators.

Graphs represent the relative OD of TNF-α mRNA (A); iNOS mRNA (B) and iNOS protein (C) expression in the hippocampus. ***, ### indicate p<0.001. * compared hypoxia vs normoxia and normoxia treated Ca2EDTA. # compared hypoxia treated Ca2EDTA vs hypoxia. N- Normoxia, NED-Normoxia treated with Ca2EDTA, IH-Hypoxia and HED-Hypoxia treated with Ca2EDTA. Lane 1,2-Normoxia, Lane 3,4-Normoxia treated with Ca2EDTA, Lane 5,6- Hypoxia and Lane 7,8- Hypoxia treated with Ca2EDTA. M indicate Marker lane. TNF-α: Forward Primer: 5′- CTGAGTTGGTCCCCCTTCT - 3′, Reverse primer: 5′ – CCGATGGGTTGTACCTTGT -3′ (240 bp); iNOS: Forward primer: 5′-ATGGACCAGTATAAGGCAAG-3′, Reverse primer: 5′-CTCTGGATGAGCCTATATTG-3′ (427 bp).

https://doi.org/10.1371/journal.pone.0110253.g004

thumbnail
Figure 5. Effect of Ca2EDTA on hypobaric hypoxia induced alteration in the expression of inflammatory mediators.

Photomicrographs show the expression of iNOS (A), COX-2 (C) and TNF-α (E), counter stained with Hoechst 33342 on CA3 hippocampal regions of normoxia (a), normoxia treated with Ca2EDTA (b), hypoxia (c), hypoxia treated with Ca2EDTA (d) (Magnification ×400). Graph represents relative mean fluorescence intensity of iNOS (B), COX-2 (D) and TNF-α (F) expression in hippocampal sections of CA3 region. *** indicate p<0.001, **, ## indicate p<0.01, # indicate p<0.05. * compared hypoxia vs normoxia treated Ca2EDTA. # compared hypoxia treated Ca2EDTA vs hypoxia. NED-normoxia treated with Ca2EDTA, IH-hypoxia and HED-hypoxia treated with Ca2EDTA. Scale bar  = 5 µm.

https://doi.org/10.1371/journal.pone.0110253.g005

Effect of Ca2EDTA on hypobaric hypoxia induced alteration in NADPH Oxidase activity

NADPH oxidase, widely expressed in various tissues including neurons and microglia, catalyses the conversion of oxygen to super oxide anions (-•O2). The -•O2 serves as precursor of a complex array of highly reactive potent oxidants like OH and ONOO, thereby further accelerating the neuronal damage. Its role in hypobaric hypoxia still remains to be evaluated. Herein, we observed that NADPH oxidase activity was significantly (P<0.001) increased in the hypoxic group as compared to normoxia and normoxic treated group (one-way ANOVA: F(2,12) = 21.10). Treatment with zinc chelator significantly (P<0.001) reduced NADPH oxidase activity in the hipocampii of hypoxic animals as compared with untreated hypoxic animals (Fig 6B).

thumbnail
Figure 6. Effect of Ca2EDTA on nitrite content, NADPH oxidase activity, LPO level, and PARPactivity.

Graph represents the total nitrite level (A), NADPH Oxidase activity (B), lipid peroxidation (C) and PARP activity assay (D) in the hippocampal tissue homogenate. ***, ### indicate p<0.001, **, ## indicate p<0.01. * compared hypoxia vs normoxia and normoxia treated Ca2EDTA, # compared hypoxia treated Ca2EDTA vs hypoxia. N-Normoxia, NED-Normoxia Treated with Ca2EDTA, IH-Hypoxia and HED-Hypoxia Treated with Ca2EDTA.

https://doi.org/10.1371/journal.pone.0110253.g006

Effect of Ca2EDTA on hypobaric hypoxia induced lipid peroxidation and NO levels

Hippocampii of hypoxic animals showed significant (P<0.001) elevation in malondialdehyde levels than normoxia and normoxia treated animals (one-way ANOVA: F(3,20) = 104.4). Ca2EDTA treatment significantly (P<0.001) attenuated the hypoxia induced increase in MDA levels (Fig 6C). NO is known to release free zinc from the metallothioneins and its involvement in neuronal injury is well documented. In the present study, we made an effort to evaluate the effect of Ca2EDTA on hypobaric hypoxia induced elevation in nitric oxide. Hipocampii of hypoxic animals showed a significant (P<0.001) elevation in NO level, which was higher than normoxia and normoxic treated groups (one-way ANOVA: F(3,20) = 64.45). However, treatment with zinc chelator significantly (P<0.001) decreased the hypoxia induced increase in nitric oxide level (Fig 6A).

Effect of Ca2EDTA on hypobaric hypoxia induced alteration in PARP activity

Poly(ADP Ribose)Polymerase (PARP) functions as a DNA repair enzyme, but its over-activation results in energy failure and cellular damage. In this study, hypobaric hypoxia showed significantly (P<0.001) increased PARP activity and chelation of free zinc with Ca2EDTA resulted in significant (P<0.05) reduction of PARP activity when compared with hypoxic group (one-way ANOVA: F(2,17) = 21.23). Further, it was noticed that the hypoxia treated group showed insignificantly elevated PARP activity as compared with normoxia and normoxic treated group (Fig 6D).

Effect of Ca2EDTA on hypobaric hypoxia induced alteration in apoptotic mediators

We observed that hypobaric hypoxia showed significant (mRNA expression P<0.001; protein expression P<0.05) increase in the relative Bax/Bcl-2 expression as compared with the normoxic and normoxic treated groups in the hippocampus (one-way ANOVA: F(3,20) = 75.45; F(2,23) = 12.86, respectively). Ca2EDTA treated group showed significant reduction (mRNA expression P<0.001; protein expression P<0.05) in the relative Bax/Bcl-2 expression when compared with the hypoxic group (Fig 7A&B). Further, caspase family of proteases play a central role in apoptosis. We observed that caspase 9 & 8 activities were significantly (P<0.01) increased when compared with normoxia and normoxia treated groups. Treatment with zinc chelator significantly (P<0.01) reduced both caspase 9 & 8 activities as compared with hypoxic group (one-way ANOVA: F(2,16) = 9.876; F(2,17) = 54.62, respectively) (Fig 8C & D). In addition, the activity of effector protease, caspase 3 was significantly (P<0.01) increased in hippocampii of hypoxic group when compared with normoxia and normoxia treated groups (one-way ANOVA: F(2,21) = 25.05). Treatment with zinc chelator significantly (P<0.01) reduced the caspase 3 activity as compared with hypoxic group (Fig 8E).

thumbnail
Figure 7. Effect of free chelatable zinc on hypobaric hypoxia induced alteration in Bax/Bcl-2 expression.

Graph represents the relative mRNA expression of Bax/Bcl-2 in the hippocampus (A). Lane 1-Normoxia, Lane 2-Normoxia treated with Ca2EDTA, Lane 3- Hypoxia and Lane 4- Hypoxia treated with Ca2EDTA. Graph (B) represents the relative protein expression of Bax/Bcl-2 in the hippocampus. Lane 1-Normoxia, Lane 2-Normoxia treated with Ca2EDTA, Lane 3- Hypoxia and Lane 4- Hypoxia treated with Ca2EDTA. *, # indicate p<0.05. ***, ### indicate p<0.001. * compared hypoxia vs normoxia and normoxia treated Ca2EDTA. # compared hypoxia treated Ca2EDTA vs hypoxia. N- Normoxia, NED-Normoxia Treated with Ca2EDTA, IH-Hypoxia and HED-Hypoxia Treated with Ca2EDTA. Bcl-2: Forward -5′-CTGGCATCTTCTCCTTCCAG-3′; Reverse - 5′-GACGGTAGCGACGAGAGAAG-3′ (183 bp); Bax: Forward: 5′-TGAAGACAGGGGCCTTTTTG-3′; Reverse: 5′-AATTCGCCGGAGACACTCG-3′ (139 bp).

https://doi.org/10.1371/journal.pone.0110253.g007

thumbnail
Figure 8. Effect of free chelatable zinc on hypobaric hypoxia induced apoptosis.

A. Photomicrographs of TUNEL stained hippocampus CA3 region (A) of normoxia (a), normoxia treated with Ca2EDTA (b), hypoxia (c), and hypoxia treated with Ca2EDTA (d) (Magnification 400X). Arrow head shows TUNEL positive neurons. Graph (B) represents the number of TUNEL positive neurons from the sections of hippocampus CA3 region, caspase 9 (C), caspase 8 (D) and caspase 3 (E) activities. *** indicate p<0.01, **, ## indicate p<0.01. * compared hypoxia vs normoxia and normoxia treated Ca2EDTA and hypoxia treated with Ca2EDTA. # compared hypoxia treated Ca2EDTA vs hypoxia. N- Normoxia, NED-Normoxia Treated with Ca2EDTA, IH-Hypoxia and HED-Hypoxia Treated with Ca2EDTA. Scale bar  = 5 µm.

https://doi.org/10.1371/journal.pone.0110253.g008

Effect of Ca2EDTA on hypobaric hypoxia induced apoptosis (TUNEL assay)

The number of apoptotic neurons in the hippocampus CA3 region was significantly (P<0.001) higher in the hypoxic group as compared with the normoxic group. Further, treatment with zinc chelator showed significant (P<0.01) protection against apoptosis in the hippocampus during hypobaric hypoxia (one-way ANOVA: F(3,24) = 30.05). There was significant (P<0.05) difference in the number of apoptotic neurons between hypoxic treated and the normoxic groups (Fig 8A & B).

Discussion

Molecular pathways underlying hypoxia induced neurotoxicity and memory dysfunction are multifaceted involving oxidative stress, mitochondrial dysfunction and activation of apoptotic cascades [1], [30], [31]. Zinc is manifested in neurodegenerative conditions like ischemic hypoxia in the hippocampal region, a vital region involved in the memory processes [32]. The zinc homeostasis involves a variety of zinc transporters and zinc buffering proteins. In the present study, we observed that hypobaric hypoxia upregulated the expression of ZIP-6 and ZnT-1, which act by transporting zinc from extracellular space to cytoplasm and vice-versa, respectively. Ca2EDTA could partially attenuate the hypoxia induced alteration in the expression of both ZnT-1 and ZIP-6. Further, hypobaric hypoxia resulted in the elevation of MT-3, a brain specific intracellular zinc buffering protein and was significantly attenuated by the zinc chelator. These observations and the results from our previous study suggest that increased levels of transporters and zinc buffering protein (MT-3) under hypoxic condition may lead to higher intracellular levels of free zinc particularly in the pyramidal neurons of hypoxia susceptible CA-3 region resulting in neuronal damage and memory impairment [20].

Zinc chelation modulates the oxidative stress and pro-inflammatory gene expression

Metallothioneins are highly efficient free radical scavengers, known to be involved in cytoprotection [33] and are associated with oxidative stress and inflammation [34], [35]. Our results showed elevated levels of malondialdehyde, a marker of lipid peroxidation suggesting the existence of oxidative stress during hypobaric hypoxia. Further, the mRNA and protein expression of iNOS, an inflammatory mediator, was also up-regulated in the hippocampus of hypoxic animals. In addition, we observed increased NO levels in the hippocampii of the hypoxic group almost twice the level of normoxic group. This inflammatory response was associated with up-regulation of COX-2 and TNF-α expression in the hypoxic animals. Ca2EDTA showed neuroprotective effect against hypobaric hypoxia by reducing the oxidative stress and regulation of inflammatory genes in the hippocampus after exposure to hypobaric hypoxia. These results suggest that the free zinc released during hypoxia might play an instrumental role in hypoxia mediated pathophysiological alterations in the hippocampus. Our previous findings and other reports suggest that iNOS mediated NO release is associated with memory dysfunction and neuronal damage [3], [36]. Moreover, it has been reported that iNOS plays a detrimental role in the behaviour of animals following global cerebral ischemia [36], intermittent hypoxia [37], intracerebroventricular administration of β-amyloid [38] and lypopolysaccharides (LPS) [39]. Earlier reports also suggested the involvement of nitric oxide in pathophysiology of neurological disorders under hypoxic condition [3], [40], [41], [42], which is endogenously produced by iNOS [43]. Our present study has revealed an interesting fact that free zinc released during hypobaric hypoxia might be an essential factor for the consequences exerted by iNOS. This might be due to the effect of free zinc on the alteration of iNOS expression at transcriptional level. Moreover, iNOS dimers are stabilized with zinc metal at the centre, which is necessary for the synthesis of NO [44]. It is known that the expression of iNOS is regulated by HIF-1α [45], a key regulator of cellular and systemic responses to hypoxia. Here in, we observed that mRNA expression of HIF-1α was not altered in any of the groups but the protein expression was found to be elevated in the hypoxic animals. Evidences suggest that during hypoxia, increasing ROS might contribute to the stabilization of HIF-1α [9], [46], [47] and subsequently translocated to the nucleus where it binds constitutively expressed HIF1-β, forming HIF-1. HIF-1 binds hypoxia response elements on numerous genes encoding proteins such as erythropoietin, vascular endothelial growth factor (VEGF) and numerous glycolytic enzymes necessary for responding to hypoxic stress [6], [7], [8], thereby influencing metabolic adaptation, cell survival and apoptosis [48]. In the present study, Ca2EDTA reduced the elevated expression of HIF-1α at protein level on exposure to hypobaric hypoxia, which suggests that free zinc released during hypobaric hypoxia might contribute to the stabilization of HIF-1α [49]. The relative contribution of ROS to stabilize HIF-1α suggested by others has been substantiated in our study. Hence, we further investigated whether zinc chelator alters the ROS generation in the hippocampus of hypoxic animals. NADPH oxidase, a major source of ROS in biological system including mouse hippocampal neurons [50] was found to have increased activity in the hypoxic animals. The hypoxic animals treated with zinc chelator markedly attenuated the hypoxia induced elevated NADPH oxidase activity in hippocampus and hence the reduction in reactive oxygen species. Similar to our results, NADPH oxidase activation has been reported in rats and gerbils following cerebral ischemia [51], [52]. Further, toxic concentration of zinc is known to damage the cortical neurons via NADPH mediated superoxide release [53]. Moreover, free radicals mediated lipid peroxidation and inflammation associated with microglia activation in the hippocampus of ischemic animals was attenuated by NADPH oxidase inhibitor [52]. These reports suggest that hypobaric hypoxia induced zinc release mediates ROS production, which is an essential component for the activation and stabilization of HIF-1α [54], [55].

Zinc chelation attenuated the hypobaric hypoxia induced apoptosis in hippocampus

In the present study, we observed that hypobaric hypoxia resulted in generation of nitric oxide as well as superoxide, which are known to facilitate the production of a peroxynitrite. Peroxynitrite is a highly potent oxidant that has a destructive effect on DNA. PARP, an enzyme known to maintain the integrity of DNA has been implicated in neurodegenerative disorders and PARP inhibitors were found to be protective against neuronal injury [27], [56]. We observed that hypoxia resulted in activation of PARP in the hippocampus, which was effectively suppressed by the zinc chelator. Current findings suggest that free zinc released during hypobaric hypoxia modulates PARP activity resulting in HIF-1α accumulation in the presence of nitrative and oxidative stress [57]. The involvement of hypobaric hypoxia induced zinc release in mediating apoptotic neuronal death was evident, as the zinc chelator treatment to hypoxic animals resulted in reduced programmed cell death in CA3 region of hippocampus, as revealed from TUNEL assay. The results of TUNEL assay were substantiated by caspase activity assays. The experimental results showed increased activity of caspase 9 and 3, the markers for the initiation and execution of apoptosis, respectively. Zinc chelation showed significant reduction in the activity of both caspase 9 and 3 in the hippocampal homogenate of hypoxic animals. It has been recently reported that zinc modulates the expression of caspase 9&3 in the hippocampus following transient global ischemia in gerbils [32], which strongly support our present findings. Further, it is known that Bcl-2 family proteins play a prominent anti-apoptotic role by acting upstream of caspase activation and PARP has a modulatory effect on Bcl-2 expression [58]. In our present study, we observed that the Bax/Bcl-2 ratio was increased in the hypoxic animals thereby suggesting a bax mediated caspase activation and neuronal death. Reduction in Bax/Bcl-2 ratio and neuronal apoptosis, as observed in zinc chelator treated group substantiates the involvement of zinc in neurotoxicity during hypoxic condition. These results suggest that free zinc is associated with oxidative stress mediated DNA damage, leading to the activation PARP and further resulting in Bax mediated cellular damage. However, it is also possible that free zinc might have a direct regulatory role in the expression of Bcl-2 and/or Bax, which needs further investigation. Current findings suggest that hypobaric hypoxia induces intrinsic apoptotic mechanisms and are selectively localized to particular cellular populations within the hippocampus, especially CA3 region. Further, upregulation of TNF-α expression after exposure to hypobaric hypoxia prompted us to study whether extrinsic factors are also involved. Interestingly, we observed that caspase 8 activity was also increased in hippocampiis of hypoxic animals, which was attenuated by zinc chelator. All these data suggest that free zinc released during hypobaric hypoxia might be involved in the intrinsic as well as extrinsic pathway of the apoptotic mechanism. Similar to our observations in hippocampus, it has been reported that cerebral hypoxia resulted in increased activity of caspase-9 and caspase-3 in the cerebral cortex of newborn piglets [59], [60]. Moreover, hypoxia resulted in oxidative stress mediated increase in pro-apoptotic proteins such as Bax, APAF-1 with subsequent down-regulation of anti-apoptotic Bcl-2 and activation of caspase-3 [61] leading to neuronal apoptosis.

Conclusions

It can be concluded that zinc chelator could effectively attenuate the hypobaric hypoxia induced superoxide generation via NADPH oxidase, leading to a destabilization effect on HIF-1α and resultant maintenance of low expression of genes such as iNOS, MT-3, TNFα, etc. Apart from protection against neuronal inflammation, the zinc chelator could also influence the apoptotic neuronal damage induced by hypobaric hypoxia in the hippocampus CA3 region of brain (Fig 9). Altogether, the results of the present study enhance our understanding of the role of free chelatable zinc in the pathophysiology of neuronal inflammation and apoptosis, implying that chelation of free zinc may be useful in the therapy of neuropathological conditions such as hypobaric hypoxia.

thumbnail
Figure 9. Schematic illustration of the role of free chelatable zinc during hypoxic conditions.

Zinc chelator alters the accumulation of free zinc in the hippocampus thus, reduces oxidative stress and inhibits PARP activation. Oxidative stress and PARP collectively modulate Bcl-2 expression resulting in Bax mediated activation of caspases leading to apoptotic neurodegeneration during hypoxic stress which is reduced significantly by the treatment zinc chelator.

https://doi.org/10.1371/journal.pone.0110253.g009

Acknowledgments

The authors acknowledge Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, India for the facilities provided.

Author Contributions

Conceived and designed the experiments: AK UM. Performed the experiments: UM KD. Analyzed the data: AK UM KD. Contributed reagents/materials/analysis tools: AK. Wrote the paper: AK UM.

References

  1. 1. Maiti P, Singh SB, Mallick B, Muthuraju S, Ilavazhagan G (2008) High altitude memory impairment is due to neuronal apoptosis in hippocampus, cortex and striatum. J Chem Neuroanat 36: 227–238.
  2. 2. Hota SK, Barhwal K, Ray K, Singh SB, Ilavazhagan G (2008) Ceftriaxone rescues hippocampal neurons from excitotoxicity and enhances memory retrieval in chronic hypobaric hypoxia. Neurobiol Learn Mem 89: 522–532.
  3. 3. Udayabanu M, Kumaran D, Nair RU, Srinivas P, Bhagat N, et al. (2008) Nitric oxide associated with iNOS expression inhibits acetylcholinesterase activity and induces memory impairment during acute hypobaric hypoxia. Brain Res 1230: 138–149.
  4. 4. Chao WH, Askew EW, Roberts DE, Wood SM, Perkins JB (1999) Oxidative stress in humans during work at moderate altitude. J Nutr 129: 2009–2012.
  5. 5. Moller P, Loft S, Lundby C, Olsen NV (2001) Acute hypoxia and hypoxic exercise induce DNA strand breaks and oxidative DNA damage in humans. FASEB J 15: 1181–1186.
  6. 6. Godzich M, Hodnett M, Frank JA, Su G, Pespeni M, et al. (2006) Activation of the stress protein response prevents the development of pulmonary edema by inhibiting VEGF cell signaling in a model of lung ischemia-reperfusion injury in rats. FASEB J 20: 1519–1521.
  7. 7. Mura M, dos Santos CC, Stewart D, Liu M (2004) Vascular endothelial growth factor and related molecules in acute lung injury. J Appl Physiol 97: 1605–1617.
  8. 8. Maulik N, Das DK (2002) Potentiation of angiogenic response by ischemic and hypoxic preconditioning of the heart. J Cell Mol Med 6: 13–24.
  9. 9. Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, et al. (2000) Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem 275: 25130–25138.
  10. 10. MacMicking J, Xie QW, Nathan C (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15: 323–350.
  11. 11. Guzik TJ, Korbut R, Adamek-Guzik T (2003) Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 54: 469–487.
  12. 12. Cross AR, Segal AW (2004) The NADPH oxidase of professional phagocytes–prototype of the NOX electron transport chain systems. Biochim Biophys Acta 1657: 1–22.
  13. 13. Suschek CV, Schnorr O, Kolb-Bachofen V (2004) The role of iNOS in chronic inflammatory processes in vivo: is it damage-promoting, protective, or active at all? Curr Mol Med 4: 763–775.
  14. 14. Szabo C (2003) Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 140–141: 105–112.
  15. 15. Semenov DG, Belyakov AV, Samoilov MO (2009) Moderate hypobaric hypoxia modifies Ca2+-mediated glutamatergic signal transduction in rat cerebral cortex. Bull Exp Biol Med 147: 185–188.
  16. 16. Stork CJ, Li YV (2006) Intracellular zinc elevation measured with a "calcium-specific" indicator during ischemia and reperfusion in rat hippocampus: a question on calcium overload. J Neurosci 26: 10430–10437.
  17. 17. Vallee BL, Falchuk KH (1993) The biochemical basis of zinc physiology. Physiol Rev 73: 79–118.
  18. 18. Cuajungco MP, Lees GJ (1997) Zinc metabolism in the brain: relevance to human neurodegenerative disorders. Neurobiol Dis 4: 137–169.
  19. 19. Capasso M, Jeng JM, Malavolta M, Mocchegiani E, Sensi SL (2005) Zinc dyshomeostasis: a key modulator of neuronal injury. J Alzheimers Dis 8: 93–108 discussion 209–115.
  20. 20. Udayabanu M, Kumaran D, Katyal A (2012) Free chelatable zinc modulates the cholinergic function during hypobaric hypoxia-induced neuronal damage: an in vivo study. Neuroscience 202: 434–445.
  21. 21. Yokoyama M, Koh J, Choi DW (1986) Brief exposure to zinc is toxic to cortical neurons. Neurosci Lett 71: 351–355.
  22. 22. Choi DW, Yokoyama M, Koh J (1988) Zinc neurotoxicity in cortical cell culture. Neuroscience 24: 67–79.
  23. 23. Lees GJ, Lehmann A, Sandberg M, Hamberger A (1990) The neurotoxicity of zinc in the rat hippocampus. Neurosci Lett 120: 155–158.
  24. 24. Koh JY (2001) Zinc and disease of the brain. Mol Neurobiol 24: 99–106.
  25. 25. Koh JY, Suh SW, Gwag BJ, He YY, Hsu CY, et al. (1996) The role of zinc in selective neuronal death after transient global cerebral ischemia. Science 272: 1013–1016.
  26. 26. Glowinski J, Iversen LL (1966) Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem 13: 655–669.
  27. 27. Kumaran D, Udayabanu M, Nair RU, R A, Katyal A (2008) Benzamide protects delayed neuronal death and behavioural impairment in a mouse model of global cerebral ischemia. Behav Brain Res 192: 178–184.
  28. 28. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351–358.
  29. 29. Yi XY, Li VX, Zhang F, Yi F, Matson DR, et al. (2006) Characteristics and actions of NAD(P)H oxidase on the sarcoplasmic reticulum of coronary artery smooth muscle. Am J Physiol Heart Circ Physiol 290: H1136–1144.
  30. 30. Hota SK, Barhwal K, Singh SB, Ilavazhagan G (2007) Differential temporal response of hippocampus, cortex and cerebellum to hypobaric hypoxia: a biochemical approach. Neurochem Int 51: 384–390.
  31. 31. Nouette-Gaulain K, Biais M, Savineau JP, Marthan R, Mazat JP, et al. (2011) Chronic hypoxia-induced alterations in mitochondrial energy metabolism are not reversible in rat heart ventricles. Can J Physiol Pharmacol 89: 58–66.
  32. 32. Wang T, Zheng W, Xu H, Zhou JM, Wang ZY (2010) Clioquinol inhibits zinc-triggered caspase activation in the hippocampal CA1 region of a global ischemic gerbil model. PLoS One 5: e11888.
  33. 33. Vallee BL (1995) The function of metallothionein. Neurochem Int 27: 23–33.
  34. 34. Hidalgo J, Aschner M, Zatta P, Vasak M (2001) Roles of the metallothionein family of proteins in the central nervous system. Brain Res Bull 55: 133–145.
  35. 35. Kondoh M, Inoue Y, Atagi S, Futakawa N, Higashimoto M, et al. (2001) Specific induction of metallothionein synthesis by mitochondrial oxidative stress. Life Sci 69: 2137–2146.
  36. 36. Mori K, Togashi H, Ueno KI, Matsumoto M, Yoshioka M (2001) Aminoguanidine prevented the impairment of learning behavior and hippocampal long-term potentiation following transient cerebral ischemia. Behav Brain Res 120: 159–168.
  37. 37. Li RC, Row BW, Kheirandish L, Brittian KR, Gozal E, et al. (2004) Nitric oxide synthase and intermittent hypoxia-induced spatial learning deficits in the rat. Neurobiol Dis 17: 44–53.
  38. 38. Tran MH, Yamada K, Olariu A, Mizuno M, Ren XH, et al. (2001) Amyloid beta-peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors. FASEB J 15: 1407–1409.
  39. 39. Yamada K, Komori Y, Tanaka T, Senzaki K, Nikai T, et al. (1999) Brain dysfunction associated with an induction of nitric oxide synthase following an intracerebral injection of lipopolysaccharide in rats. Neuroscience 88: 281–294.
  40. 40. Brown GC (2010) Nitric oxide and neuronal death. Nitric Oxide 23: 153–165.
  41. 41. Brown GC, Neher JJ (2010) Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol 41: 242–247.
  42. 42. Maiti P, Singh SB, Ilavazhagan G (2010) Nitric oxide system is involved in hypobaric hypoxia-induced oxidative stress in rat brain. Acta Histochem 112: 222–232.
  43. 43. Griffith OW, Stuehr DJ (1995) Nitric oxide synthases: properties and catalytic mechanism. Annu Rev Physiol 57: 707–736.
  44. 44. Mazumdar T, Eissa NT (2005) Preferential recognition of undisruptable dimers of inducible nitric oxide synthase by a monoclonal antibody directed against an N-terminal epitope. J Immunol 174: 2314–2317.
  45. 45. Hu R, Dai A, Tan S (2002) Hypoxia-inducible factor 1 alpha upregulates the expression of inducible nitric oxide synthase gene in pulmonary arteries of hyposic rat. Chin Med J (Engl) 115: 1833–1837.
  46. 46. Brune B, Zhou J (2003) The role of nitric oxide (NO) in stability regulation of hypoxia inducible factor-1alpha (HIF-1alpha). Curr Med Chem 10: 845–855.
  47. 47. Haddad JJ, Land SC (2001) A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1alpha. FEBS Lett 505: 269–274.
  48. 48. Maxwell PH, Pugh CW, Ratcliffe PJ (2001) Activation of the HIF pathway in cancer. Curr Opin Genet Dev 11: 293–299.
  49. 49. Chun YS, Choi E, Kim GT, Lee MJ, Lee SE, et al. (2000) Zinc induces the accumulation of hypoxia-inducible factor (HIF)-1alpha, but inhibits the nuclear translocation of HIF-1beta, causing HIF-1 inactivation. Biochem Biophys Res Commun 268: 652–656.
  50. 50. Tejada-Simon MV, Serrano F, Villasana LE, Kanterewicz BI, Wu GY, et al. (2005) Synaptic localization of a functional NADPH oxidase in the mouse hippocampus. Mol Cell Neurosci 29: 97–106.
  51. 51. Green SP, Cairns B, Rae J, Errett-Baroncini C, Hongo JA, et al. (2001) Induction of gp91-phox, a component of the phagocyte NADPH oxidase, in microglial cells during central nervous system inflammation. J Cereb Blood Flow Metab 21: 374–384.
  52. 52. Wang Q, Tompkins KD, Simonyi A, Korthuis RJ, Sun AY, et al. (2006) Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus. Brain Res 1090: 182–189.
  53. 53. Noh KM, Koh JY (2000) Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. J Neurosci 20: RC111.
  54. 54. Kim I, Kim CH, Seo GH, Kim HS, Lee J, et al. (2008) Inhibitory effect of zinc on hypoxic HIF-1 activation in astrocytes. Neuroreport 19: 1063–1066.
  55. 55. Yun YJ, Li SH, Cho YS, Park JW, Chun YS (2010) Survivin mediates prostate cell protection by HIF-1alpha against zinc toxicity. Prostate 70: 1179–1188.
  56. 56. Strosznajder RP, Gadamski R, Czapski GA, Jesko H, Strosznajder JB (2003) Poly(ADP-ribose) polymerase during reperfusion after transient forebrain ischemia: its role in brain edema and cell death. J Mol Neurosci 20: 61–72.
  57. 57. Martinez-Romero R, Martinez-Lara E, Aguilar-Quesada R, Peralta A, Oliver FJ, et al. (2008) PARP-1 modulates deferoxamine-induced HIF-1alpha accumulation through the regulation of nitric oxide and oxidative stress. J Cell Biochem 104: 2248–2260.
  58. 58. Strosznajder R, Gajkowska B (2006) Effect of 3-aminobenzamide on Bcl-2, Bax and AIF localization in hippocampal neurons altered by ischemia-reperfusion injury. the immunocytochemical study. Acta Neurobiol Exp (Wars) 66: 15–22.
  59. 59. Khurana P, Ashraf QM, Mishra OP, Delivoria-Papadopoulos M (2002) Effect of hypoxia on caspase-3, -8, and -9 activity and expression in the cerebral cortex of newborn piglets. Neurochem Res 27: 931–938.
  60. 60. Mishra OP, Delivoria-Papadopoulos M (2006) Effect of neuronal nitric oxide synthase inhibition on caspase-9 activity during hypoxia in the cerebral cortex of newborn piglets. Neurosci Lett 401: 81–85.
  61. 61. Barhwal K, Singh SB, Hota SK, Jayalakshmi K, Ilavazhagan G (2007) Acetyl-L-carnitine ameliorates hypobaric hypoxic impairment and spatial memory deficits in rats. Eur J Pharmacol 570: 97–107.